Page last updated: 2024-12-08

aminoimidazole ribotide

Description

5-amino-1-(5-phospho-beta-D-ribosyl)imidazole : A 1-(phosphoribosyl)imidazole that is 5-aminoimidazole in which the proton at position 1 has been replaced by a 5-phospho-beta-D-ribofuranosyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID161500
CHEMBL ID1230914
CHEBI ID138560
MeSH IDM0083458

Synonyms (26)

Synonym
CHEMBL1230914
(2r,3r,4s,5r)-2-(5-amino-1h-imidazol-1-yl)-tetrahydro-5-(phosphomethyl)furan-3,4-diol
5-amino-1-ribofuranosylimidazole 5'-phosphate
aminoimidazole ribonucleotide
1h-imidazol-5-amine, 1-(5-o-phosphono-beta-d-ribofuranosyl)-
imidazole-5-amino-1-beta-d-ribofuranosyl-5'-(dihydrogen phosphate)
1-(5'-phosphoribosyl)-5-aminoimidazole
25635-88-5
5-aminoimidazole ribonucleotide
5-aminoimidazole ribotide
5-amino-1-(5-phospho-beta-d-ribosyl)imidazole
aminoimidazole ribotide
1-(5-phospho-d-ribosyl)-5-aminoimidazole
5'-phosphoribosyl-5-aminoimidazole
C03373
5-amino-1-beta-d-ribofuranosyl-5'-(dihydrogen phosphate)-imidazole
1-(5-o-phosphono-beta-d-ribofuranosyl)-1h-imidazol-5-amine
CHEBI:138560
[(2r,3s,4r,5r)-5-(5-aminoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
1h-imidazol-5-amine, 1-(5-o-phosphono-beta-d-ribofuranosyl)
{[(2r,3s,4r,5r)-5-(5-amino-1h-imidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid
Q2817103
PDACUKOKVHBVHJ-XVFCMESISA-N
[5-(5-aminoimidazol-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxyphosphonic acid
DTXSID60948494
((2r,3s,4r,5r)-5-(5-amino-1h-imidazol-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
1-(phosphoribosyl)imidazole
aminoimidazoleAny member of the class of imidazoles carrying at least one amino substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1272393Binding affinity to Bacillus anthracis PurE by intrinsic tryptophan fluorescence analysis2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (28.00)18.7374
1990's8 (32.00)18.2507
2000's5 (20.00)29.6817
2010's5 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.84 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com